Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 3 of 3 results for ritlecitinib

  1. Ritlecitinib for treating severe alopecia areata in people 12 years and over (TA958)

    Evidence-based recommendations on ritlecitinib (Litfulo) for treating severe alopecia areata in people 12 years and over.

    Technology appraisal guidance
    Published
    27 March 2024
    View recommendations

    Sections for TA958

  2. Ritlecitinib for treating non-segmental vitiligo in people 12 years and over [ID6584]

    Awaiting development [GID-TA11744] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  3. Thousands could benefit from treatment for severe alopecia

    New one-a-day tablet for people with severe hair loss due to alopecia areata recommended by NICE

    News
    Last updated
    23 February 2024